West Nile Vaccines for Horses in Canada 2025: Top 5 Options — Recombitek, West Nile-Innovator, Vetera WNV, EquiNile, Prestige WNV (Which One Protects Your Horse This Mosquito Season?)
Published on Monday, August 25, 2025
Vaccines that provide immunity against West Nile virus in horses, available in killed and recombinant formulations and recommended prior to peak mosquito season. This category covers products licensed and commonly used in Canada to reduce the risk of West Nile neuroinvasive disease in equines. Horse owners, barn managers and veterinarians choose these vaccines based on proven safety profiles, speed and strength of immune response, dosing schedule, suitability for pregnant mares and foals, regional availability, and cost. In Canadian markets where mosquito activity and risk vary by province and season, buyers often prefer vaccines that are easy to store and administer, have clear booster guidelines, and are supported by veterinary recommendations and field data.
Top Picks Summary
West Nile-Innovator
West Nile-Innovator is positioned as a market-leading, widely adopted West Nile vaccine for horses due to a long track record of field use and broad veterinary distribution, making it a default choice for large stables and boarding operations. Compared with the other listed vaccines it emphasizes proven real-world efficacy and supply-chain availability, which can translate into lower acquisition risk and predictable budgeting for equine operations that prioritize established performance over newest-technology premiums.
$70-140 CAD
What the Science Says About West Nile Vaccination
A growing body of veterinary research and field experience supports routine vaccination of horses against West Nile virus. Studies and field surveillance consistently show that both killed (inactivated) and recombinant vaccines stimulate protective antibody responses, reduce the incidence of severe neurologic disease, and are important tools for herd-level risk reduction when administered before peak mosquito activity. Canadian veterinarians commonly recommend a pre-season vaccination strategy with an appropriate primary series and timely boosters to maintain protective immunity through high-risk months.
Vaccine types: Inactivated (killed) vaccines and recombinant vaccines (for example, canarypox-vectored formulations) both generate protective humoral responses; recombinant vaccines are often highlighted for a favorable safety profile.
Timing and immunity: Primary vaccination series typically requires two doses several weeks apart, with measurable seroconversion often occurring within 2 to 4 weeks after the second dose; boosters maintain protection and are usually given annually or sooner in high-risk areas.
Safety: Field studies and post-marketing surveillance report low rates of adverse reactions; certain recombinant formulations have been used safely in pregnant mares and young stock when given according to label directions.
Effectiveness in the field: Outbreak surveillance and vaccine effectiveness studies indicate vaccinated horses are substantially less likely to develop severe neurologic signs versus unvaccinated horses, especially when the vaccination schedule is current.
Practical considerations: Cold-chain handling, compliance with booster intervals, and timing before local mosquito season are key drivers of real-world protection; consult local veterinary guidance for province-specific timing.
Frequently Asked Questions
Should I choose West Nile-Innovator for my boarding barn?
West Nile-Innovator is a default choice for large stables and boarding operations because it’s an inactivated whole-virus vaccine with a long track record of field use and a well-understood safety profile, rated 4.3.
What does West Nile-Innovator’s dosing schedule look like?
West Nile-Innovator is typically given as a two-dose initial series followed by annual boosters for ongoing protection.
Is Vetera WNV cheaper than West Nile-Innovator in Canada?
The provided info lists Vetera WNV as cost-competitive for owners looking to reduce per-dose spend, but it doesn’t include any exact prices for Vetera WNV or West Nile-Innovator.
Which vaccine fits routine herd vaccination: Vetera WNV?
Vetera WNV is positioned as suitable for routine herd vaccination programs, with a typical two-dose primary series; it’s rated 4.0.
Conclusion
In Canada, protecting your horse from West Nile virus is a seasonal but crucial part of preventive care. The five vaccines featured here — West Nile-Innovator, Vetera WNV, EquiNile, Prestige WNV, and Recombitek Equine West Nile — represent the commonly used killed and recombinant options that Canadian veterinarians and owners evaluate before mosquito season. Many practitioners often favour Recombitek Equine West Nile for its balance of safety and rapid immune response, but the right choice depends on your horse’s age, pregnancy status, previous vaccine history, and local risk. We hope you found what you were looking for; use the site search to refine by product features, dosing schedules, or province-specific guidance to expand or narrow your results.